Contract Services
Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards
▪ Vetter celebrates its second consecutive year earning this award in six categories with three additional honors in the CDMO Leadership Awards&nbs...
March 28, 2023 | News
YS Biopharma's PIKA COVID-19 Vaccine Shows Better Antibody Response Than Inactivated Vaccine in Phase II Study
The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inactivated COVID-19 vaccine, measured by GMT of neutralizing a...
March 28, 2023 | News
Enveric Biosciences Selects Australian CRO, Avance Clinical
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of nove...
March 27, 2023 | News
WuXi Biologics Reports Remarkable 2022 Annual Results
2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...
March 23, 2023 | News
Emmes Acquires Essex Management
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovatio...
March 22, 2023 | News
Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18
Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...
March 22, 2023 | News
Samsung Biologics to build Plant 5 for Bio Campus II expansion.
The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics' second Bio Campus, ...
March 17, 2023 | News
Mabwell begins first human trial of iron-regulating drug 9MW3011
The study (CTR20230046) is a phase 1, single center, randomized, double-blind，placebo-controlled, ascending dose study to evaluate the safety, ...
March 15, 2023 | News
Antengene's ATG-022 Phase I CLINCH Trial for Solid Tumor Treatment Receives IND Approval in China
- Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Assoc...
March 14, 2023 | News
H1 Launches Advanced Diversity Insights and Clinical Trial Performance Insights
H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level ...
March 13, 2023 | News
Boan Biotech Completes Patient Enrollment for Aflibercept Trial in China
Aflibercept is a homodimeric fusion protein consisting of portions of human vascular endothelial growth factor receptor (VEGFR) extracellular domains (VEGF...
March 13, 2023 | News
Vetter strengthens worldwide commitment to sustainable business practices
Globally, Vetter is one of over 300 companies in the pharma and biotech industrythat have signed the UN Global Compact Membership drives expansion of ec...
March 08, 2023 | News
Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance
Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published the findings of an...
March 07, 2023 | News
GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS
GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered into strategic collaboration...
March 07, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
